Armelle Blanchard

COSMYX is a French company specialized in 3D printing using Fused Filament Fabrication (FFF) technology. 🚀 We design and manufacture professional-grade NOVA and SUPER NOVA 3D printers, developed to meet the demands of industrial production. Our automated 3D microfactories, MIRA and NEXUS, enable continuous 24/7 manufacturing. We also offer on-demand 3D printing services, training for the use of our products, and a responsive customer support service based in Île-de-France. The company is committed to the "Industry of the Future" and provides innovative solutions to integrate the circular economy into industrial manufacturing, relocate production, and reduce environmental impact. ♻️

NEOSYAD develops products for the use of adipose tissue in plastic and reconstructive surgery (lipofilling), as well as in regenerative medicine. Our range of patented AdiMate/Adipure devices is revolutionizing the practice of lipofilling for plastic surgery, by automating the preparation of adipose tissue while optimizing graft effectiveness. Lipofilling is a surgical process in which adipose tissue (fat) is transferred from one area of the body to another, on the same person and in the same operating time (autologous grafting). This technique is very common and generally necessary for breast reconstruction after breast cancer, as it enables "natural" reconstruction with highly satisfactory results. It is also frequently used in cosmetic surgery for gluteal augmentation (buttocks), as well as for breast augmentation, with or without implants. In these indications alone, lipofilling accounts for over 1.5 million procedures per year worldwide. NEOSYADs products are based on the scientific expertise of its founders and the experience of its teams in developing innovative medical devices. NEOSYADs automated systems incorporate software and protocols specifically developed for surgical applications, based on the most recent scientific work on autografts and adipose tissue biology, as well as on several years of NEOSYADs own R&D. Surgery ; Adipose tissue ; Cellular biology ; Tissue engineering ; Regenerative medicine

HEPHAISTOS-Pharma est une startup en biotechnologie développant des immunothérapies anti-tumorales permettant de révolutionner les traitements contre le cancer en décuplant lefficacité des anticorps monoclonaux et en permettant le traitement de tumeurs incurables.

COSMYX is a French company specialized in 3D printing using Fused Filament Fabrication (FFF) technology. 🚀 We design and manufacture professional-grade NOVA and SUPER NOVA 3D printers, developed to meet the demands of industrial production. Our automated 3D microfactories, MIRA and NEXUS, enable continuous 24/7 manufacturing. We also offer on-demand 3D printing services, training for the use of our products, and a responsive customer support service based in Île-de-France. The company is committed to the "Industry of the Future" and provides innovative solutions to integrate the circular economy into industrial manufacturing, relocate production, and reduce environmental impact. ♻️

NEOSYAD develops products for the use of adipose tissue in plastic and reconstructive surgery (lipofilling), as well as in regenerative medicine. Our range of patented AdiMate/Adipure devices is revolutionizing the practice of lipofilling for plastic surgery, by automating the preparation of adipose tissue while optimizing graft effectiveness. Lipofilling is a surgical process in which adipose tissue (fat) is transferred from one area of the body to another, on the same person and in the same operating time (autologous grafting). This technique is very common and generally necessary for breast reconstruction after breast cancer, as it enables "natural" reconstruction with highly satisfactory results. It is also frequently used in cosmetic surgery for gluteal augmentation (buttocks), as well as for breast augmentation, with or without implants. In these indications alone, lipofilling accounts for over 1.5 million procedures per year worldwide. NEOSYADs products are based on the scientific expertise of its founders and the experience of its teams in developing innovative medical devices. NEOSYADs automated systems incorporate software and protocols specifically developed for surgical applications, based on the most recent scientific work on autografts and adipose tissue biology, as well as on several years of NEOSYADs own R&D. Surgery ; Adipose tissue ; Cellular biology ; Tissue engineering ; Regenerative medicine

Premier réseau de « business angels » au féminin en France et premier réseau en Europe, Femmes Business Angels réunit plus de 150 femmes qui investissent personnellement dans des start-up à fort potentiel de croissance et les accompagnent afin de les aider à émerger et à se développer. Les investisseuses de FBA s’intéressent aux entreprises innovantes à fort potentiel de tous secteurs, en amorçage ou en développement, dirigées par des hommes ou par des femmes et cherchant à lever entre 200K€ euros et 2M€. Réseau conjuguant convivialité et professionnalisme, FBA souhaite à la fois encourager les femmes à participer à l’aventure passionnante des « business angels » et jouer un rôle actif dans la création d’entreprise en soutenant les entrepreneurs de talent qui « osent » ! 💁‍♀️Envie de devenir business angel et rejoindre une communauté de femmes qui sinvestissent ? https://www.femmesbusinessangels.org/fr/devenir-ba/ 🚀 En levée de fonds ? https://airtable.com/appvr78pLk4Cbsp65/shruP4jJ2vrI04UcX Présidente : Catherine Malaval Vice-présidente : Françoise Huguet-Devallet Secrétaire générale : Marie-Pierre Sbardella Tresoriere : Dominique Mucchielli

HEPHAISTOS-Pharma est une startup en biotechnologie développant des immunothérapies anti-tumorales permettant de révolutionner les traitements contre le cancer en décuplant lefficacité des anticorps monoclonaux et en permettant le traitement de tumeurs incurables.